Daniel Gaudet Selected Research

COVID-19

1/2021	Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.
1/2021	SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Gaudet Research Topics

Disease

40	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 11/2005
36	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2023 - 06/2004
26	Hypertriglyceridemia 04/2024 - 06/2002
20	Homozygous Familial Hypercholesterolemia 03/2024 - 05/2002
17	Pancreatitis 04/2024 - 06/2010
16	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 12/2023 - 06/2009
16	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 07/2002
16	Obesity 06/2016 - 05/2002
15	Hypercholesterolemia 12/2023 - 11/2005
15	Type 2 Diabetes Mellitus (MODY) 07/2022 - 05/2004
12	Hypertension (High Blood Pressure) 01/2019 - 05/2003
10	Abdominal Obesity 01/2015 - 02/2002
9	Dyslipidemias (Dyslipidemia) 02/2024 - 03/2010
9	Inborn Genetic Diseases (Disease, Hereditary) 05/2023 - 03/2010
9	Atherosclerosis 12/2021 - 05/2002
8	Xanthomatosis (Xanthoma) 01/2023 - 03/2005
6	Injection Site Reaction 11/2022 - 03/2010
6	Glucose Intolerance 04/2014 - 05/2002
6	Insulin Resistance 04/2013 - 02/2005
6	Hypertriglyceridemic Waist 08/2012 - 07/2002
5	Costello Syndrome 05/2023 - 02/2015
5	Hyperlipoproteinemia Type III (Broad Beta Disease) 08/2022 - 12/2010
5	Inflammation (Inflammations) 01/2022 - 01/2011
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2020 - 01/2004
4	Non-alcoholic Fatty Liver Disease 02/2024 - 12/2015
4	Rare Diseases (Rare Disease) 01/2023 - 02/2015
4	Body Weight (Weight, Body) 12/2020 - 12/2004
3	Myocardial Infarction 01/2024 - 08/2007
3	Coronary Disease (Coronary Heart Disease) 10/2023 - 01/2020
3	Muscular Diseases (Myopathy) 01/2019 - 02/2012
3	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2017 - 10/2010
3	Overweight 06/2016 - 01/2011
3	Hyperinsulinism (Hyperinsulinemia) 08/2012 - 02/2002
2	Thrombocytopenia (Thrombopenia) 02/2024 - 01/2023
2	Stroke (Strokes) 01/2024 - 08/2007
2	COVID-19 01/2021 - 01/2021
2	Myalgia 01/2019 - 11/2015
2	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 01/2018 - 12/2015
2	Metabolic Diseases (Metabolic Disease) 09/2013 - 07/2006
2	Diabetes Mellitus 09/2013 - 02/2005

Drug/Important Bio-Agent (IBA)

40	Triglycerides (Triacylglycerol)IBA 04/2024 - 02/2002
38	oxidized low density lipoproteinIBA 03/2024 - 02/2002
38	LDL CholesterolIBA 03/2024 - 04/2008
35	LipidsIBA 01/2024 - 06/2002
23	HDL CholesterolIBA 04/2024 - 02/2002
23	Lipoproteins (Lipoprotein)IBA 12/2023 - 02/2002
19	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 05/2002
14	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2002
12	ApolipoproteinsIBA 04/2024 - 01/2004
10	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 04/2023 - 06/2002
9	evinacumabIBA 11/2023 - 11/2019
9	LDL Receptors (LDL Receptor)IBA 01/2023 - 01/2006
9	CholesterolIBA 11/2020 - 02/2002
8	Monoclonal AntibodiesIBA 03/2024 - 09/2014
8	evolocumabIBA 03/2024 - 01/2015
8	Apolipoproteins B (ApoB)IBA 07/2022 - 02/2002
8	alirocumabIBA 01/2022 - 07/2012
7	ISIS 304801IBA 02/2024 - 12/2014
7	Biomarkers (Surrogate Marker)IBA 07/2022 - 02/2005
7	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 02/2002
7	HDL LipoproteinsIBA 10/2020 - 06/2002
7	Ezetimibe (Zetia)FDA Link 12/2019 - 05/2002
6	microsomal triglyceride transfer proteinIBA 01/2023 - 02/2002
6	BMS201038IBA 01/2023 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 11/2019 - 05/2004
5	Proprotein Convertase 9IBA 03/2024 - 09/2018
5	Apolipoprotein C-IIIIBA 12/2023 - 07/2015
5	Lipoprotein(a)IBA 11/2022 - 11/2012
5	Rosuvastatin Calcium (Crestor)FDA Link 01/2018 - 09/2013
4	C-Reactive ProteinIBA 01/2019 - 08/2007
4	Insulin (Novolin)FDA Link 04/2013 - 06/2002
3	Small Interfering RNA (siRNA)IBA 02/2024 - 11/2022
3	Angiopoietin-Like Protein 3IBA 12/2023 - 01/2021
3	AngiopoietinsIBA 01/2023 - 11/2019
3	Messenger RNA (mRNA)IBA 01/2022 - 04/2014
3	Fibric Acids (Fibrates)IBA 06/2020 - 12/2010
3	ChylomicronsIBA 01/2020 - 01/2013
3	LeptinIBA 01/2016 - 05/2003
3	mipomersenIBA 12/2015 - 03/2010
3	Apolipoprotein E2IBA 01/2015 - 06/2002
3	Apolipoproteins E (ApoE)IBA 01/2015 - 12/2010
3	AdiponectinIBA 02/2012 - 02/2005
2	Antisense OligonucleotidesIBA 01/2023 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 02/2007
2	CER-001IBA 10/2020 - 05/2015
2	Glycerol (Glycerine)FDA LinkGeneric 06/2020 - 02/2005
2	VLDL LipoproteinsIBA 01/2020 - 01/2015
2	VLDL CholesterolIBA 12/2019 - 01/2015
2	Apolipoprotein C-II (ApoC2)IBA 07/2018 - 01/2017
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 06/2016
2	Poly TIBA 01/2018 - 06/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 02/2014
2	Cholesterol Ester Transfer ProteinsIBA 01/2018 - 06/2004
2	Antihypertensive Agents (Antihypertensives)IBA 06/2016 - 04/2015
2	Fenofibrate (CiL)FDA LinkGeneric 01/2016 - 01/2004
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2015 - 02/2007

Therapy/Procedure

30	Therapeutics 02/2024 - 05/2002
4	Precision Medicine 01/2019 - 01/2014
3	Fat-Restricted Diet (Diet, Fat Restricted) 05/2020 - 06/2010
3	Blood Component Removal (Apheresis) 01/2019 - 05/2002